Jushi Holdings (JUSHF) Net Cash Flow (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Net Cash Flow of -$6.8 million for Q2 2026, down 156.66% year-over-year from $12.0 million in Q2 2025, and down 143.55% quarter-over-quarter from $15.7 million in Q1 2026.
Jushi Holdings (JUSHF) Net Cash Flow (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Net Cash Flow for 6 consecutive years, with -$6.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Cash Flow fell 156.66% year-over-year to -$6.8 million; the TTM figure through Jun 2026 stood at $10.2 million (up 204.33% YoY), while the FY2025 annual figure was $5.3 million, up 152.92% from the prior year.
- Net Cash Flow fell to -$6.8 million in Q2 2026 per JUSHF's latest filing, from $15.7 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $15.7 million in Q1 2026 and bottomed at -$32.2 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$3.3 million across 5 years, with a median of -$1.6 million in 2023.
- Annual changes were most pronounced in 2024 — Net Cash Flow tumbled 662.02% — and 2025, when it soared 982.73%.
- Jushi Holdings' Net Cash Flow stood at -$5.1 million in 2022, then jumped by 116.55% to $836000.0 in 2023, then plunged by 284.81% to -$1.5 million in 2024, then surged by 129.58% to $457000.0 in 2025, then tumbled by 1591.68% to -$6.8 million in 2026.
- Business Quant data shows JUSHF's Net Cash Flow at -$6.8 million in Q2 2026, $15.7 million in Q1 2026, and $457000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | -6.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.82 Mn |
| Jun 30, 2026 | -6.82 Mn |
| Mar 31, 2026 | 15.66 Mn |
| Mar 31, 2026 | 15.66 Mn |
| Dec 31, 2025 | 457,000.00 |
| Dec 31, 2025 | 457,000.00 |
| Sep 30, 2025 | 928,000.00 |
| Sep 30, 2025 | 928,000.00 |
| Jun 30, 2025 | -2.66 Mn |
| Jun 30, 2025 | -2.66 Mn |
| Mar 31, 2025 | 6.54 Mn |
| Mar 31, 2025 | 6.54 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Sep 30, 2024 | -12.14 Mn |
| Sep 30, 2024 | -12.14 Mn |
| Jun 30, 2024 | 4.47 Mn |
| Jun 30, 2024 | 4.47 Mn |
| Mar 31, 2024 | -741,000.00 |
| Mar 31, 2024 | -741,000.00 |